Sulfasalazine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71610-706 -
Package NDC
71610-706-70 -
Package NDC
71610-706-80 -
Application number
NDA007073 -
SPL ID
a5313f88-2d90-4f75-afb8-9dde2a069fa7 -
SPL set ID
bf5137fe-60ed-4497-8521-eeb0a684fabf -
UNII
3XC8GUZ6CB -
RxCUI
198232
What the source publishes
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Active ingredients
- Sulfasalazine
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA AUTHORIZED GENERIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Sulfasalazine",
"splId": "a5313f88-2d90-4f75-afb8-9dde2a069fa7",
"labels": [
{
"setId": "bf5137fe-60ed-4497-8521-eeb0a684fabf",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bf5137fe-60ed-4497-8521-eeb0a684fabf",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bf5137fe-60ed-4497-8521-eeb0a684fabf"
}
],
"routes": [
"ORAL"
],
"labeler": "Aphena Pharma Solutions - Tennessee, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "120 TABLET in 1 BOTTLE (71610-706-70)",
"package_ndc": "71610-706-70",
"identifierStatus": "well-formed",
"marketing_start_date": "20230516"
},
{
"sample": false,
"description": "180 TABLET in 1 BOTTLE (71610-706-80)",
"package_ndc": "71610-706-80",
"identifierStatus": "well-formed",
"marketing_start_date": "20230516"
}
],
"productId": "71610-706_a5313f88-2d90-4f75-afb8-9dde2a069fa7",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "71610-706",
"deaSchedule": null,
"genericName": "Sulfasalazine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "SULFASALAZINE",
"strength": "500 mg/1"
}
],
"applicationNumber": "NDA007073",
"marketingCategory": "NDA AUTHORIZED GENERIC",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20030701",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175781",
"M0000971"
],
"unii": [
"3XC8GUZ6CB"
],
"rxcui": [
"198232"
],
"spl_set_id": [
"bf5137fe-60ed-4497-8521-eeb0a684fabf"
],
"pharm_class_cs": [
"Aminosalicylic Acids [CS]"
],
"pharm_class_epc": [
"Aminosalicylate [EPC]"
],
"manufacturer_name": [
"Aphena Pharma Solutions - Tennessee, LLC"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71610-706_a5313f88-2d90-4f75-afb8-9dde2a069fa7"